Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-052670
Filing Date
2025-04-10
Accepted
2025-04-10 07:05:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A eq-defa14a-2025.htm DEFA14A 22535
2 GRAPHIC img256154445_0.jpg GRAPHIC 1203639
3 GRAPHIC img256154445_1.jpg GRAPHIC 492788
  Complete submission text file 0000950170-25-052670.txt   2359771
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38692 | Film No.: 25826469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)